Concepedia

Masami Kusaka

MK

37

Publications

2.5K

Citations

24

H-Index

1984

Active since

Affiliations

Takeda (Japan)(Current)

Tokushima University

Tokyo University of Agriculture and Technology

Institute of Agrobiological Sciences

Nagoya University

Masami Kusaka is an author at Takeda (Japan) specializing in medicine, pharmacology, and endocrinology.

Top concepts

MedicinePharmacologyEndocrinologyPhysiologyDrug DiscoveryBiochemistryNatural SciencesMedicinal ChemistryCell BiologyPharmacotherapy

Publications per year

1984–2018

37

Publications

37

Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.

Takahito Hara, Jun‐ichi Miyazaki, Hideo Araki et al. · PubMed · 2003 · 427 citations

Molecular Pharmacology, Androgen Receptor, Urology +12

Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent

Masami Kusaka, Katsuichi Sudo, Takeshi Fujita et al. · Biochemical and Biophysical Research Communications · 1991 · 322 citations

Inflammation, Antifungal Agent, Angiogenesis +6

Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)

Masami Kusaka, K Sudo, Etsuya Matsutani et al. · British Journal of Cancer · 1994 · 243 citations · Full text

Angiogenesis, Endothelial Cell Growth, Medicine +10

Stimulation of prostaglandin E2 synthesis in cloned osteoblastic cells of mouse (MC3T3-E1) by epidermal growth factor.

Kazushige Yokota, Masami Kusaka, Takehiro Ohshima et al. · Journal of Biological Chemistry · 1986 · 167 citations · Full text

Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer

Tomohiro Kaku, Takenori Hitaka, Akio Ojida et al. · Bioorganic & Medicinal Chemistry · 2011 · 126 citations · Full text

Medicinal Chemistry, Selective 17,20-Lyase Inhibitor, Potential Utility +9

Rows per page

1–5 of 37